Bringing the fundamentals into focus…
Back to Kyntra Bio, Inc.
How Kyntra Bio, Inc. stacks up
KYNB · against 22 other Healthcare companies of similar size
Overall
10/ 100
Near the bottom of its peers.
Ranked #20 of 23 · scores higher than 14% of peers
Bars: peers in each 10-point band of the overall score5 peers with an overall score of 10–19, including KYNB · Click a bar to see the companies
The four scores behind it
Overall = average of valuation, growth, profitability and safety percentile (categories without data are skipped)Ranking by overall score
Top 5 and the companies ranked around KYNB| Rank | Company | Market cap | Overall | Valuation | Growth | Profitability | Risk |
|---|---|---|---|---|---|---|---|
| 1 | 272M HKD (≈$35M) | 59 | 97 | 62 | 42 | 1 / 2 | |
| 2 | 14.3B KRW (≈$10M) | 53 | 71 | 70 | 39 | 2 / 2 | |
| 3 | 3.5B JPY (≈$24M) | 48 | 65 | 39 | 49 | 1 / 2 | |
| 3 | 298M SEK (≈$30M) | 48 | 8 | 94 | 8 | 0 / 2 | |
| 3 | 276M SEK (≈$28M) | 48 | 0 | 93 | 3 | 0 / 2 | |
| 16 | 34M USD | 19 | 33 | 0 | 1 | 1 / 2 | |
| 17 | 17M USD | 18 | 8 | 21 | 15 | 2 / 2 | |
| 18 | 252M HKD (≈$32M) | 17 | 0 | — | 29 | 2 / 2 | |
| 19 | 17M USD | 16 | 8 | 14 | 41 | 2 / 2 | |
| 20 | 17M USD | 10 | 33 | 0 | 2 | 2 / 2 | |
| 21 | 390.5B IDR (≈$24M) | 8 | 8 | 2 | 14 | 2 / 2 | |
| 22 | 18M AUD (≈$12M) | 7 | 0 | — | 8 | 2 / 2 | |
| 23 | 3.4B JPY (≈$23M) | 5 | 0 | 7 | 2 / 2 |
Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score